10-Q Filing

CARDINAL HEALTH INC CIK: 721371 Q2 2017

Filing Information

Form Type	10-Q
Accession Number	`0000721371-17-000015`
Period End Date	20161231
Filing Date	20170207
Fiscal Year	2017
Fiscal Period	Q2
XBRL Instance	cah-20161231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 62 Income Statement 84 Cash Flow Statement 74 Comprehensive Income 28

Balance Sheet 62 line items

Line Item	Tag	Value	Unit	Period
Preferred shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.62B	USD	Point-in-time
Common shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.88B	USD	Point-in-time
Common shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.36B	USD	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.32B	USD	Point-in-time
Common shares, issued	`CommonStockSharesIssued`	364.00M	shares	Point-in-time
Trade receivables, net	`ReceivablesNetCurrent`	$7.53B	USD	Point-in-time
Trade receivables, net	`ReceivablesNetCurrent`	$7.41B	USD	Point-in-time
Common shares, issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Inventories, net	`InventoryNet`	$10.62B	USD	Point-in-time
Inventories, net	`InventoryNet`	$11.91B	USD	Point-in-time
Common shares in treasury	`TreasuryStockShares`	42.00M	shares	Point-in-time
Common shares in treasury	`TreasuryStockShares`	11.00M	shares	Point-in-time
Prepaid expenses and other	`OtherAssetsCurrent`	$1.58B	USD	Point-in-time
Prepaid expenses and other	`OtherAssetsCurrent`	$1.82B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$21.96B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$23.15B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.80B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.86B	USD	Point-in-time
Goodwill and other intangibles, net	`IntangibleAssetsNetIncludingGoodwill`	$9.43B	USD	Point-in-time
Goodwill and other intangibles, net	`IntangibleAssetsNetIncludingGoodwill`	$9.28B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$944.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$736.00M	USD	Point-in-time
Total assets	`Assets`	$34.12B	USD	Point-in-time
Total assets	`Assets`	$35.02B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$18.86B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$17.31B	USD	Point-in-time
Current portion of long-term obligations and other short-term borrowings	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$587.00M	USD	Point-in-time
Current portion of long-term obligations and other short-term borrowings	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$603.00M	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$1.55B	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$1.81B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$21.01B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$19.70B	USD	Point-in-time
Long-term obligations, less current portion	`LongTermDebtAndCapitalLeaseObligations`	$4.86B	USD	Point-in-time
Long-term obligations, less current portion	`LongTermDebtAndCapitalLeaseObligations`	$4.95B	USD	Point-in-time
Deferred income taxes and other liabilities	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$2.69B	USD	Point-in-time
Deferred income taxes and other liabilities	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$2.78B	USD	Point-in-time
Redeemable noncontrolling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$115.00M	USD	Point-in-time
Redeemable noncontrolling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$117.00M	USD	Point-in-time
Authorized500 thousand shares, Issuednone	`PreferredStockValue`	-	USD	Point-in-time
Authorized500 thousand shares, Issuednone	`PreferredStockValue`	-	USD	Point-in-time
Authorized755 million shares, Issued327 million shares and 364 million shares at December 31, 2016 and June 30, 2016, respectively	`CommonStockValue`	$3.01B	USD	Point-in-time
Authorized755 million shares, Issued327 million shares and 364 million shares at December 31, 2016 and June 30, 2016, respectively	`CommonStockValue`	$2.67B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$6.42B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$4.60B	USD	Point-in-time
Common Shares in treasury, at cost: 11 million shares and 42 million shares at December 31, 2016 and June 30 2016, respectively	`TreasuryStockValue`	$2.76B	USD	Point-in-time
Common Shares in treasury, at cost: 11 million shares and 42 million shares at December 31, 2016 and June 30 2016, respectively	`TreasuryStockValue`	$783.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-170.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-116.00M	USD	Point-in-time
Total Cardinal Health, Inc. shareholders' equity	`StockholdersEquity`	$6.55B	USD	Point-in-time
Total Cardinal Health, Inc. shareholders' equity	`StockholdersEquity`	$6.32B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$18.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$17.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.57B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.34B	USD	Point-in-time
Total liabilities, redeemable noncontrolling interests and shareholders equity	`LiabilitiesAndStockholdersEquity`	$34.12B	USD	Point-in-time
Total liabilities, redeemable noncontrolling interests and shareholders equity	`LiabilitiesAndStockholdersEquity`	$35.02B	USD	Point-in-time

Income Statement 84 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	$31.45B	USD	1 Quarter
Revenue	`Revenues`	$59.50B	USD	2 Qtrs
Revenue	`Revenues`	$33.15B	USD	1 Quarter
Revenue	`Revenues`	$65.19B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsSold`	$31.55B	USD	1 Quarter
Cost of products sold	`CostOfGoodsSold`	$62.00B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsSold`	$29.84B	USD	1 Quarter
Cost of products sold	`CostOfGoodsSold`	$56.31B	USD	2 Qtrs
Gross margin	`GrossProfit`	$1.61B	USD	1 Quarter
Gross margin	`GrossProfit`	$3.19B	USD	2 Qtrs
Gross margin	`GrossProfit`	$1.60B	USD	1 Quarter
Gross margin	`GrossProfit`	$3.19B	USD	2 Qtrs
Distribution, selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$910.00M	USD	1 Quarter
Distribution, selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.83B	USD	2 Qtrs
Distribution, selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$922.00M	USD	1 Quarter
Distribution, selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.76B	USD	2 Qtrs
Restructuring and employee severance	`RestructuringCharges`	$16.00M	USD	2 Qtrs
Restructuring and employee severance	`RestructuringCharges`	$2.00M	USD	1 Quarter
Restructuring and employee severance	`RestructuringCharges`	$7.00M	USD	1 Quarter
Restructuring and employee severance	`RestructuringCharges`	$14.00M	USD	2 Qtrs
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$237.00M	USD	2 Qtrs
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$219.00M	USD	2 Qtrs
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$115.00M	USD	1 Quarter
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$114.00M	USD	1 Quarter
Impairments and loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-9.00M	USD	1 Quarter
Impairments and loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-17.00M	USD	2 Qtrs
Impairments and loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-17.00M	USD	1 Quarter
Impairments and loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-12.00M	USD	2 Qtrs
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$9.00M	USD	1 Quarter
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$-19.00M	USD	1 Quarter
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$9.00M	USD	2 Qtrs
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$-20.00M	USD	2 Qtrs
Operating earnings	`OperatingIncomeLoss`	$1.08B	USD	2 Qtrs
Operating earnings	`OperatingIncomeLoss`	$1.18B	USD	2 Qtrs
Operating earnings	`OperatingIncomeLoss`	$563.00M	USD	1 Quarter
Operating earnings	`OperatingIncomeLoss`	$542.00M	USD	1 Quarter
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$-6.00M	USD	2 Qtrs
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$-3.00M	USD	2 Qtrs
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$2.00M	USD	1 Quarter
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$-7.00M	USD	1 Quarter
Interest expense, net	`InterestExpense`	$44.00M	USD	1 Quarter
Interest expense, net	`InterestExpense`	$90.00M	USD	2 Qtrs
Interest expense, net	`InterestExpense`	$88.00M	USD	2 Qtrs
Interest expense, net	`InterestExpense`	$45.00M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.09B	USD	2 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$491.00M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$985.00M	USD	2 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$520.00M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$167.00M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$194.00M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$377.00M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$351.00M	USD	2 Qtrs
Net earnings	`ProfitLoss`	$324.00M	USD	1 Quarter
Net earnings	`ProfitLoss`	$634.00M	USD	2 Qtrs
Net earnings	`ProfitLoss`	$710.00M	USD	2 Qtrs
Net earnings	`ProfitLoss`	$326.00M	USD	1 Quarter
Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net earnings attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$633.00M	USD	2 Qtrs
Net earnings attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$324.00M	USD	1 Quarter
Net earnings attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$709.00M	USD	2 Qtrs
Net earnings attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$326.00M	USD	1 Quarter
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$2.16	USD	2 Qtrs
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.99	USD	2 Qtrs
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$0.99	USD	1 Quarter
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.02	USD	1 Quarter
Diluted (in shares)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$1.02	USD	1 Quarter
Diluted (in shares)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$2.14	USD	2 Qtrs
Diluted (in shares)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$0.98	USD	1 Quarter
Diluted (in shares)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$1.97	USD	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	319.00M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	329.00M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	318.00M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	329.00M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	332.00M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	321.00M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	319.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	332.00M	shares	1 Quarter
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.90	USD	2 Qtrs
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.77	USD	2 Qtrs
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.39	USD	1 Quarter
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.45	USD	1 Quarter

Cash Flow Statement 74 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$324.00M	USD	1 Quarter
Net earnings	`ProfitLoss`	$634.00M	USD	2 Qtrs
Net earnings	`ProfitLoss`	$710.00M	USD	2 Qtrs
Net earnings	`ProfitLoss`	$326.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$306.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$339.00M	USD	2 Qtrs
Gain (Loss) on Sale of Investments	`GainLossOnSaleOfInvestments`	$-3.00M	USD	2 Qtrs
Gain (Loss) on Sale of Investments	`GainLossOnSaleOfInvestments`	-	USD	2 Qtrs
Impairments and loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-9.00M	USD	1 Quarter
Impairments and loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-17.00M	USD	2 Qtrs
Impairments and loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-17.00M	USD	1 Quarter
Impairments and loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-12.00M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$47.00M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$56.00M	USD	2 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$29.00M	USD	2 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$35.00M	USD	2 Qtrs
Change in fair value of contingent consideration obligation	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-14.00M	USD	2 Qtrs
Change in fair value of contingent consideration obligation	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	-	USD	2 Qtrs
Increase in trade receivables	`IncreaseDecreaseInReceivables`	$146.00M	USD	2 Qtrs
Increase in trade receivables	`IncreaseDecreaseInReceivables`	$393.00M	USD	2 Qtrs
Increase in inventories	`IncreaseDecreaseInInventories`	$1.29B	USD	2 Qtrs
Increase in inventories	`IncreaseDecreaseInInventories`	$1.56B	USD	2 Qtrs
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.43B	USD	2 Qtrs
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.56B	USD	2 Qtrs
Other accrued liabilities and operating items, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$172.00M	USD	2 Qtrs
Other accrued liabilities and operating items, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$529.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$658.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.41B	USD	2 Qtrs
Acquisition of subsidiaries, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$3.28B	USD	2 Qtrs
Acquisition of subsidiaries, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$11.00M	USD	2 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$213.00M	USD	2 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$175.00M	USD	2 Qtrs
Purchase of available for sale securities and other investments	`Purchaseofavailableforsalesecuritiesandotherinvestments`	$125.00M	USD	2 Qtrs
Purchase of available for sale securities and other investments	`Purchaseofavailableforsalesecuritiesandotherinvestments`	$88.00M	USD	2 Qtrs
Proceeds from sale of available-for-sale securities and other investments	`Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments`	$72.00M	USD	2 Qtrs
Proceeds from sale of available-for-sale securities and other investments	`Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments`	$57.00M	USD	2 Qtrs
Proceeds from maturities of available-for-sale securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$19.00M	USD	2 Qtrs
Proceeds from maturities of available-for-sale securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$39.00M	USD	2 Qtrs
Proceeds from divestitures and disposal of property and equipment and held for sale assets	`Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets`	$1.00M	USD	2 Qtrs
Proceeds from divestitures and disposal of property and equipment and held for sale assets	`Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets`	-	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-3.47B	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-237.00M	USD	2 Qtrs
Payment of contingent consideration obligation	`PaymentofContingentConsideration`	-	USD	2 Qtrs
Payment of contingent consideration obligation	`PaymentofContingentConsideration`	$23.00M	USD	2 Qtrs
Net change in short-term borrowings	`ProceedsFromRepaymentsOfShortTermDebt`	$39.00M	USD	2 Qtrs
Net change in short-term borrowings	`ProceedsFromRepaymentsOfShortTermDebt`	$33.00M	USD	2 Qtrs
Net purchase of noncontrolling interests	`PaymentsToAcquireAdditionalInterestInSubsidiaries`	$12.00M	USD	2 Qtrs
Net purchase of noncontrolling interests	`PaymentsToAcquireAdditionalInterestInSubsidiaries`	-	USD	2 Qtrs
Reduction of long-term obligations	`RepaymentsOfLongTermDebt`	$60.00M	USD	2 Qtrs
Reduction of long-term obligations	`RepaymentsOfLongTermDebt`	$4.00M	USD	2 Qtrs
Proceeds from interest rate swap terminations	`PaymentsForProceedsFromHedgeFinancingActivities`	-	USD	2 Qtrs
Proceeds from interest rate swap terminations	`PaymentsForProceedsFromHedgeFinancingActivities`	$-14.00M	USD	2 Qtrs
Net tax withholdings from share-based compensation	`Netproceedstaxwithholdingsfromsharebasedcompensation`	$-7.00M	USD	2 Qtrs
Net tax withholdings from share-based compensation	`Netproceedstaxwithholdingsfromsharebasedcompensation`	-	USD	2 Qtrs
Tax proceeds from share-based compensation	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$32.00M	USD	2 Qtrs
Tax proceeds from share-based compensation	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$32.00M	USD	2 Qtrs
Dividends on common shares	`PaymentsOfDividendsCommonStock`	$259.00M	USD	2 Qtrs
Dividends on common shares	`PaymentsOfDividendsCommonStock`	$293.00M	USD	2 Qtrs
Payments for Repurchase of Common Stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	2 Qtrs
Payments for Repurchase of Common Stock	`PaymentsForRepurchaseOfCommonStock`	$600.00M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-886.00M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-222.00M	USD	2 Qtrs
Effect of exchange rates changes on cash and equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-10.00M	USD	2 Qtrs
Effect of exchange rates changes on cash and equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-10.00M	USD	2 Qtrs
Net decrease in cash and equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-2.29B	USD	2 Qtrs
Net decrease in cash and equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-475.00M	USD	2 Qtrs
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$4.62B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.88B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.36B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.32B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$4.62B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.88B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.36B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.32B	USD	Point-in-time

Comprehensive Income 28 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$324.00M	USD	1 Quarter
Net earnings	`ProfitLoss`	$634.00M	USD	2 Qtrs
Net earnings	`ProfitLoss`	$710.00M	USD	2 Qtrs
Net earnings	`ProfitLoss`	$326.00M	USD	1 Quarter
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-78.00M	USD	1 Quarter
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-28.00M	USD	1 Quarter
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-80.00M	USD	2 Qtrs
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-73.00M	USD	2 Qtrs
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-1.00M	USD	1 Quarter
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$26.00M	USD	2 Qtrs
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$24.00M	USD	1 Quarter
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-1.00M	USD	2 Qtrs
Total other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-29.00M	USD	1 Quarter
Total other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-54.00M	USD	1 Quarter
Total other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-54.00M	USD	2 Qtrs
Total other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-74.00M	USD	2 Qtrs
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$270.00M	USD	1 Quarter
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$580.00M	USD	2 Qtrs
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$636.00M	USD	2 Qtrs
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$297.00M	USD	1 Quarter
Less: comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Less: comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Less: comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Less: comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$635.00M	USD	2 Qtrs
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$270.00M	USD	1 Quarter
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$579.00M	USD	2 Qtrs
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$297.00M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.